These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 6799642)

  • 1. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
    Watkins JB; Klaassen CD
    J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
    Gregus Z; Watkins JB; Thompson TN; Klaassen CD
    J Pharmacol Exp Ther; 1983 May; 225(2):256-62. PubMed ID: 6405026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals.
    Gregus Z; Madhu C; Goon D; Klaassen CD
    Drug Metab Dispos; 1988; 16(4):527-33. PubMed ID: 2903018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats.
    Yamamura N; Imura-Miyoshi K; Naganuma H
    Drug Metab Dispos; 2000 Dec; 28(12):1484-6. PubMed ID: 11095587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choleretic effect of valproic acid in the rat.
    Watkins JB; Klaassen CD
    Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats.
    Tong V; Teng XW; Karagiozov S; Chang TK; Abbott FS
    Free Radic Biol Med; 2005 Jun; 38(11):1471-83. PubMed ID: 15890621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside in neonatal rats.
    Watkins JB; Klaassen CD
    Drug Metab Dispos; 1985; 13(2):186-91. PubMed ID: 2859166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
    Chrungoo VJ; Reen RK; Singh K; Singh J
    Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
    Yamamura N; Imura K; Naganuma H; Nishimura K
    Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content.
    Singh J; Dubey RK; Atal CK
    J Pharmacol Exp Ther; 1986 Feb; 236(2):488-93. PubMed ID: 3080587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated.
    Howell SR; Hazelton GA; Klaassen CD
    J Pharmacol Exp Ther; 1986 Mar; 236(3):610-4. PubMed ID: 3081704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat.
    Wright AW; Dickinson RG
    J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
    Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic presystemic elimination of diethylstilbestrol by rats and effect of pretreatment with inducers of UDP-glucuronosyltransferase.
    Thompson TN; Klaassen CD
    J Toxicol Environ Health; 1985; 16(3-4):615-29. PubMed ID: 3936941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers.
    Klaassen CD
    J Pharmacol Exp Ther; 1975 Nov; 195(2):311-9. PubMed ID: 1185600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear elimination and cholerteic effect of valproic acid in the monkey.
    Dickinson RG; Taylor SM; Kaufman SN; Rodgers RM; Lynn RK; Gerber N; Baughman WL
    J Pharmacol Exp Ther; 1980 Apr; 213(1):38-48. PubMed ID: 6767022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosamine prevents ethinylestradiol-induced cholestasis.
    Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
    Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of butylated hydroxyanisole on hepatic glucuronidation and biliary excretion of drugs in mice.
    Gregus Z; Klaassen CD
    J Pharm Pharmacol; 1988 Apr; 40(4):237-42. PubMed ID: 2900301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An osmotic explanation for valproic acid induced choleresis in the rat, dog and monkey.
    Dickinson RG; Harland RC; Kaufman SN; Lynn RK; Gerber N
    Arzneimittelforschung; 1982; 32(3):241-7. PubMed ID: 6805484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.